Mena FN

Systemic Scleroderma Treatment Market Expected To Grow At A CAGR Of 8.4% By 2032 ...

The systemic scleroderma treatment market is set to grow from USD 1.34 Bn in 2025 to USD 1.99 Bn by 2032, registering a CAGR of 8.4% during the forecast period LOS ANGELES, CA, UNITED STATES, February ...
Mena FN

Scleroderma Pipeline Experiences Rapid Expansion As Over 40+ Leading Companies Advance ...

DelveInsight's, “Scleroderma Pipeline Insight 2025” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in Scleroderma pipeline landscape. It covers the Scleroderma ...
News Medical

New research identifies mechanism that may lead to treatment of fibrosis in scleroderma

The prognosis for patients diagnosed with scleroderma - an autoimmune disease characterized by fibrosis of the skin - is not typically a rosy one. With limited treatment options available, those ...